CAS: 140405-36-3
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | 2-[[4-(Diethylamino)-2-hydroxyphenyl]methylene]hydrazide-4-pyridinecarboxylicacid REF: AN-AG01ENMKCAS: 140405-36-3 | ≥98%(HPLC) | A consultar | Mié 15 May 24 |
 | RSVA405 REF: TM-T8476CAS: 140405-36-3 | 98.71% | 38,00 €~1.122,00 € | Mié 22 May 24 |
 | RSVA 405 REF: 3D-QFA40536CAS: 140405-36-3 | Min. 95% | A consultar | Mié 26 Jun 24 |
![2-[[4-(Diethylamino)-2-hydroxyphenyl]methylene]hydrazide-4-pyridinecarboxylicacid](https://static.cymitquimica.com/products/AN/thumb/AG01ENMK.jpg)
2-[[4-(Diethylamino)-2-hydroxyphenyl]methylene]hydrazide-4-pyridinecarboxylicacid
CAS:140405-36-3
Fórmula:
C17H20N4O2
Pureza:
≥98%(HPLC)
Forma y color:
Solid
Peso molecular:
312.3663
Ref: AN-AG01ENMK
| 10mg | 538,00 € | |
| 50mg | A consultar | |
| 100mg | A consultar |
Entrega estimada en Estados Unidos, el Miércoles 15 de Mayo de 2024
RSVA405
CAS:140405-36-3
RSVA405 is an AMPK activator (EC50 = 1 μM), and is STAT3 inhibitor
Fórmula:
C17H20N4O2
Pureza:
98.71%
Forma y color:
Solid
Peso molecular:
312.37
Ref: TM-T8476
| 1mg | 38,00 € | |
| 2mg | 49,00 € | |
| 5mg | 80,00 € | |
| 10mg | 120,00 € | |
| 25mg | 263,00 € | |
| 50mg | 374,00 € | |
| 100mg | 537,00 € | |
| 500mg | 1.122,00 € | |
| 1ml*10 (DMSO) | 88,00 € |
Entrega estimada en Estados Unidos, el Miércoles 22 de Mayo de 2024
RSVA 405
CAS:140405-36-3
RSVA 405 is a drug that is used to reduce the risk of myopathy and …
Fórmula:
C17H20N4O2
Pureza:
Min. 95%
Peso molecular:
312.37 g/mol
Ref: 3D-QFA40536
| 5mg | A consultar | |
| 10mg | A consultar | |
| 25mg | A consultar | |
| 50mg | A consultar | |
| 100mg | A consultar |
Entrega estimada en Estados Unidos, el Miércoles 26 de Junio de 2024
